[Skip to Content]
[Skip to Content Landing]
Medical News & Perspectives
August 26, 1998

Drug Firm Suit Fails to Halt Publication of Canadian Health Technology Report

Author Affiliations

Not Available

Not Available

JAMA. 1998;280(8):683-684. doi:10.1001/jama.280.8.683-JMN0826-2-1

A CANADIAN appeals court has upheld a lower court's decision denying a pharmaceutical company's motion to block publication of a health technology report that the company contends may damage its commercial interests.

In December 1997, Bristol-Myers Squibb Canada Inc sued the Canadian Coordinating Office of Health Technology Assessment (CCOHTA) to prevent the release of its summary report on cholesterol-lowering statin drugs. The company contends that the report contains "negligent misstatements" that could negatively affect the sale of its drug Pravachol (pravastatin).